Avellino R - Search Results

1

The transcriptional and regulatory identity of erythropoietin producing cells.

Kragesteen BK, Giladi A, David E, Halevi S, Geirsdóttir L, Lempke OM, Li B, Bapst AM, Xie K, Katzenelenbogen Y, Dahl SL, Sheban F, Gurevich-Shapiro A, Zada M, Phan TS, Avellino R, Wang SY, Barboy O, Shlomi-Loubaton S, Winning S, Markwerth PP, Dekalo S, Keren-Shaul H, Kedmi M, Sikora M, Fandrey J, Korneliussen TS, Prchal JT, Rosenzweig B, Yutkin V, Racimo F, Willerslev E, Gur C, Wenger RH, Amit I. Kragesteen BK, et al. Among authors: avellino r. Nat Med. 2023 May;29(5):1191-1200. doi: 10.1038/s41591-023-02314-7. Epub 2023 Apr 27. Nat Med. 2023. PMID: 37106166

2

Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice.

Avellino R, Mulet-Lazaro R, Havermans M, Hoogenboezem R, Smeenk L, Salomonis N, Schneider RK, Rombouts E, Bindels E, Grimes L, Delwel R. Avellino R, et al. Blood Adv. 2022 Mar 8;6(5):1406-1419. doi: 10.1182/bloodadvances.2021005851. Blood Adv. 2022. PMID: 34814180 Free PMC article.

3

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

Ptasinska A, Pickin A, Assi SA, Chin PS, Ames L, Avellino R, Gröschel S, Delwel R, Cockerill PN, Osborne CS, Bonifer C. Ptasinska A, et al. Among authors: avellino r. Cell Rep. 2019 Nov 12;29(7):2120. doi: 10.1016/j.celrep.2019.10.075. Cell Rep. 2019. PMID: 31722222 Free PMC article. No abstract available.

4

Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis.

Corcione N, Pepe M, Ferraro P, Morello A, Conte S, Avellino R, Cavarretta E, Carulli E, Biondi-Zoccai G, Giordano A. Corcione N, et al. Among authors: avellino r. Ann Vasc Surg. 2020 Apr;64:151-156.e2. doi: 10.1016/j.avsg.2019.09.011. Epub 2019 Oct 17. Ann Vasc Surg. 2020. PMID: 31629846

5

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

Ptasinska A, Pickin A, Assi SA, Chin PS, Ames L, Avellino R, Gröschel S, Delwel R, Cockerill PN, Osborne CS, Bonifer C. Ptasinska A, et al. Among authors: avellino r. Cell Rep. 2019 Sep 17;28(12):3022-3031.e7. doi: 10.1016/j.celrep.2019.08.040. Cell Rep. 2019. PMID: 31533028 Free PMC article.

6

Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation.

Giordano A, Corcione N, Ferraro P, Pieri P, Avellino R, Frati G, De Persio G, Altamura L, Tomai F, Biondi-Zoccai G. Giordano A, et al. Among authors: avellino r. J Cardiovasc Med (Hagerstown). 2019 May;20(5):351-357. doi: 10.2459/JCM.0000000000000764. J Cardiovasc Med (Hagerstown). 2019. PMID: 30676494

7

Contrast Minimization With the New-Generation DyeVert Plus System for Contrast Reduction and Real-Time Monitoring During Coronary and Peripheral Procedures: First Experience.

Corcione N, Biondi-Zoccai G, Ferraro P, Messina S, Maresca G, Avellino R, Napolitano G, Cavarretta E, Giordano A. Corcione N, et al. Among authors: avellino r. J Invasive Cardiol. 2017 Aug;29(8):259-262. J Invasive Cardiol. 2017. PMID: 28756419 Free article.

8

Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.

Glass JL, Hassane D, Wouters BJ, Kunimoto H, Avellino R, Garrett-Bakelman FE, Guryanova OA, Bowman R, Redlich S, Intlekofer AM, Meydan C, Qin T, Fall M, Alonso A, Guzman ML, Valk PJM, Thompson CB, Levine R, Elemento O, Delwel R, Melnick A, Figueroa ME. Glass JL, et al. Among authors: avellino r. Cancer Discov. 2017 Aug;7(8):868-883. doi: 10.1158/2159-8290.CD-16-1032. Epub 2017 Apr 13. Cancer Discov. 2017. PMID: 28408400 Free PMC article.

9

Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.

Avellino R, Delwel R. Avellino R, et al. Blood. 2017 Apr 13;129(15):2083-2091. doi: 10.1182/blood-2016-09-687822. Epub 2017 Feb 8. Blood. 2017. PMID: 28179278 Free article. Review.

10

Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease.

Giordano A, Ferraro P, Corcione N, Messina S, Maresca G, Coscioni E, Avellino R, Giordano G, Peruzzi M, Marullo AGM, Napolitano G, Romano MF, Biondi-Zoccai G. Giordano A, et al. Among authors: avellino r. Curr Vasc Pharmacol. 2017;15(3):257-264. doi: 10.2174/1570161115666170123094523. Curr Vasc Pharmacol. 2017. PMID: 28117007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page